site stats

Ironwood pharmaceuticals revenue

WebApr 15, 2024 · The company had revenue of $107.20 million for the quarter, compared to analyst estimates of $108.23 million. Ironwood Pharmaceuticals had a net margin of 42.64% and a return on equity of 30.49%. Ironwood Pharmaceuticals’s revenue for the quarter was down 8.5% on a year-over-year basis. During the same quarter last year, the firm posted … WebFeb 17, 2024 · Michael Dabaie Ironwood Pharmaceuticals Inc. reported fourth quarter revenue and adjusted earnings above analyst expectations. Fourth quarter total revenue came to $116.7 million, down from...

Ironwood Pharmaceuticals Company Profile - Craft

WebApr 6, 2024 · Ironwood Pharmaceuticals, Inc. is a gastrointestinal (GI) healthcare company, which is advancing the treatment of GI diseases and redefining the standard of care for GI patients. It is develops and commercializes GI product opportunities in areas of significant unmet need, leveraging its demonstrated expertise and capabilities in GI diseases. WebFeb 17, 2024 · Ironwood Pharmaceuticals Inc. reported fourth quarter revenue and adjusted earnings above analyst expectations. Fourth quarter total revenue came to $116.7 million, … mounted crow https://ajrnapp.com

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Sold by …

WebApr 14, 2024 · Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Rating) was the recipient of unusually large options trading activity on Thursday. ... The company had revenue of $107.20 million for the ... WebIronwood Pharmaceuticals, headquartered in Boston, Massachusetts, and established in 1998, is a specialty and generic drug manufacturing company specializing in … WebFeb 16, 2024 · Ironwood Pharmaceuticals (IRWD) came out with quarterly earnings of $0.27 per share, missing the Zacks Consensus Estimate of $0.28 per share. This compares to … heart food bank reynoldsburg ohio

Ironwood Pharmaceuticals - IRWD Stock Forecast, Price & News

Category:Ironwood Pharmaceuticals: Contact Details and Business Profile

Tags:Ironwood pharmaceuticals revenue

Ironwood pharmaceuticals revenue

Home - Ironwood Pharmaceuticals

WebFeb 16, 2024 · Ironwood, which belongs to the Zacks Medical - Drugs industry, posted revenues of $107.2 million for the quarter ended December 2024, missing the Zacks … WebAug 21, 2024 · Constipation Treatment Market Share, Growth, Statistics, By Application, Production, Revenue & Forecast To 2027 Ironwood Pharmaceuticals, Abbott, AstraZeneca 08-21-2024 07:37 AM CET ...

Ironwood pharmaceuticals revenue

Did you know?

WebApr 10, 2024 · Ironwood Pharmaceuticals (NASDAQ:IRWD) has a market capitalization of $1.65 billion and generates $410.60 million in revenue each year. The biotechnology … WebApr 12, 2024 · Shares of IRWD opened at $10.77 on Wednesday. Ironwood Pharmaceuticals, Inc. has a 1 year low of $9.73 and a 1 year high of $12.66. The company has a market cap of $1.66 billion, a price-to ...

WebSep 30, 2024 · Ironwood Pharmaceuticals revenue is $380.0M annually. After extensive research and analysis, Zippia's data science team found the following key financial … WebApr 10, 2024 · See how Ironwood Pharmaceuticals compares to its main competitors: Hoffmann-LA Roche Inc has the most employees (101,200). Employees at AstraZeneca earn more than most of the competitors, with an average yearly salary of $112,988.

WebAccording to Ironwood Pharmaceuticals 's latest financial reports the company's current revenue (TTM) is $0.42 B . In 2024 the company made a revenue of $0.41 B an increase … WebIronwood Pharmaceuticals. Jun 2024 - Present11 months. Boston, Massachusetts, United States. Strategic finance professional at Ironwood Pharmaceuticals, a $500M revenue commercial pharmaceuticals ...

WebFeb 17, 2024 · Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results; LINZESS® (linaclotide) Achieves Blockbuster Status as U.S. Net Sales Exceed $1 Billion in 2024 – 2024 total revenue of $414 million, driven primarily by $400 million in …

WebFind company research, competitor information, contact details & financial data for Ironwood Pharmaceuticals, Inc. of Boston, MA. Get the latest business insights from Dun & Bradstreet. D&B Business Directory ... 2024 Revenue: $413.75. 2024 Revenue: $413.75. Actual. Gross Profit: $413.75; Operating Income: $232.22; Income Before Tax: $200.66; heart football black and whiteWebNov 3, 2024 · Collaboration Revenue to Ironwood: Ironwood recorded $105.2 million in collaboration revenue in the third quarter of 2024 related to sales of LINZESS in the U.S., a 5% increase compared to $100.4 million for the third quarter of 2024. See U.S. LINZESS Commercial Collaboration table at the end of the press release. heart food recipesWebFunding, Valuation & Revenue 9 Fundings Ironwood Pharmaceuticals's latest funding round was a IPO for $188M on February 12, 2010. Ironwood Pharmaceuticals's latest post-money valuation is from February 2010. Sign up for a free trial to see Ironwood Pharmaceuticals's valuations in February 2010 and more. View all funding heart football helmetWebAug 4, 2024 · Ironwood Pharmaceuticals (IRWD) came out with quarterly earnings of $0.21 per share, missing the Zacks Consensus Estimate of $0.31 per share. This compares to … heart foam wreathheart football clipartWebIronwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results February 13, 2024 Ironwood Pharmaceuticals Announces FDA Filing Acceptance and Priority Review of … heart foo fighters lettermanWebFeb 16, 2024 · Ironwood , which belongs to the Zacks Medical - Drugs industry, posted revenues of $107.2 million for the quarter ended December 2024, missing the Zacks Consensus Estimate by 3.13%. This compares... mounted crucifix bjj